SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950134-05-023047
Filing Date
2005-12-13
Accepted
2005-12-13 08:16:42
Documents
7
Period of Report
2005-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a15375e8vk.htm 8-K 12127
2 EXHIBIT 5.1 a15375exv5w1.htm EX-5.1 6272
3 EXHIBIT 10.1 a15375exv10w1.txt EX-10.1 125522
4 EXHIBIT 99.1 a15375exv99w1.htm EX-99.1 7857
5 GRAPHIC a15375a1537504.gif GRAPHIC 3484
6 GRAPHIC a15375a1537502.gif GRAPHIC 1853
7 GRAPHIC a15375a1537503.gif GRAPHIC 3496
  Complete submission text file 0000950134-05-023047.txt   165960
Mailing Address
Business Address 11588 SORRENTO VALLEY ROAD SUITE 17 SAN DIEGO CA 92121 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 051259769
SIC: 2836 Biological Products, (No Diagnostic Substances)